VL28, Inc.

DYSBIOTIC

scientific, analytical, and statistical computer software for creating and managing databases containing genomic, metagenomic, proteomic, transcriptomic, epigenetic, and metabolomic data derived from patient clinical care information and medical research data; computer software for analyzing and creating statistical models derived from patient clinical care information and medical research data in the nature of genomic, metagenomic, proteomic, transcriptomic, epigenetic, and metabolomic data;microbial preparations for pharmaceutical, veterinary and medical purposes; dietary supplements, nutritional supplements, nutraceuticals, food supplements, vegetable-based food beverages, and nutritional food bars containing microorganisms for medical therapeutic or preventative purposes; therapeutic pharmaceuticals containing microorganisms or derivatives of microorganisms for medical and veterinary use for the treatment or prevention of pre-neoplastic lesions, neoplasms, tumors, cancers, or metastases; pharmaceutical, veterinary and medical preparations and substances, namely, anti-microbial preparations and substances, anti-bacterial, anti-fungal, anti-viral, and anti-protistal preparations and substances; anti-cancer preparations and substances; combination preparations of anti-microbials, microbial preparations, and anti-cancer preparations or inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; pharmaceutical preparations and substances for the treatment of cancer, namely, microbial, anti-microbial, and anti-cancer for veterinary and medical use; pharmaceutical preparations for the treatment of infectious diseases and cancer, namely, combination preparations of anti-cancer agents, microbial preparations and anti-microbials preparations; diagnostic kits comprised of diagnostic reagents and buffers for the detection of microbes, viral, bacterial, fungal, and rotistal infections, inflammation, and biomarkers associated with pre-neoplastic lesions, neoplasms, tumors, cancers, or metastases; preparations for detecting mutations in genes for medical purposes as used in the collection of large-scale genomic, metagenomic, proteomic, transcriptomic, epigenetic, and metabolomic medical data and related clinical data;medical clinics; veterinary dentistry; behavioral analysis for medical purposes; genetic testing for medical purposes; collection and preservation of human blood for medical purposes; medical diagnostic testing for assessing pre-neoplastic lesions, neoplasms, tumors, cancers, or metastases;medical diagnostic instruments for screening, assessing, and determining appreciate courses of treatment in relation to pre-neoplastic lesions, neoplasms, tumors, cancers and metastases;electronic data storage services, namely, electronic storage of large-scale genomic, metagenomic, proteomic, transcriptomic, epigenetic, and metabolomic data and related clinical data for treatment and diagnostic purposes; database, computer-readable program and software development services, namely, development of scientific, analytical, and statistical software and related databases for use in conjunction with genomic, metagenomic, proteomic, transcriptomic, epigenetic, and metabolomic data gathered from patient clinical care information and medical research data; scientific, chemical, biochemical and microbiological research; scientific research in the field of genetics and genetic engineering of microbes; scientific research in the field of genetic and molecular tests, including tests for microbial populations in vertebrate samples; research and development of therapeutic pharmaceuticals, consumer medical products, diagnostic equipment and prognostic tools consisting of genetically engineered microorganisms, combinations of microorganisms, and individually selected microorganisms for treatment and prevention of pre-neoplastic lesions, neoplasms, tumors, cancers and metastases;

DYSBIOTIC THERAPEUTICS

scientific, analytical, and statistical computer software for creating and managing databases containing genomic, metagenomic, proteomic, transcriptomic, epigenetic, and metabolomic data derived from patient clinical care information and medical research data; computer software for analyzing and creating statistical models derived from patient clinical care information and medical research data in the nature of genomic, metagenomic, proteomic, transcriptomic, epigenetic, and metabolomic data;microbial preparations for pharmaceutical, veterinary and medical purposes; dietary supplements, nutritional supplements, nutraceuticals, food supplements, vegetable-based food beverages, and nutritional food bars containing microorganisms for medical therapeutic or preventative purposes; therapeutic pharmaceuticals containing microorganisms or derivatives of microorganisms for medical and veterinary use for the treatment or prevention of pre-neoplastic lesions, neoplasms, tumors, cancers, or metastases; pharmaceutical, veterinary and medical preparations and substances, namely, anti-microbial preparations and substances, anti-bacterial, anti-fungal, anti-viral, and anti- protistal preparations and substances; anti-cancer preparations and substances;: combination preparations of anti-microbials, microbial preparations, and anti-cancer preparations or inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; pharmaceutical preparations and substances for the treatment of cancer, namely, microbial, anti- microbial, and anti-cancer for veterinary and medical use; pharmaceutical preparations for the treatment of infectious diseases and cancer, namely, combination preparations of anti- cancer agents, microbial preparations and anti-microbials preparations; diagnostic kits comprised of diagnostic reagents and buffers for the detection of microbes, viral, bacterial, fungal, and rotistal infections, inflammation, and biomarkers associated with pre-neoplastic lesions, neoplasms, tumors, cancers, or metastases; preparations for detecting mutations in genes for medical purposes as used in the collection of large-scale genomic, metagenomic, proteomic, transcriptomic, epigenetic, and metabolomic medical data and related clinical data;medical clinics; veterinary dentistry; behavioral analysis for medical purposes; genetic testing for medical purposes; collection and preservation of human blood for medical purposes; medical diagnostic testing for assessing pre-neoplastic lesions, neoplasms, tumors, cancers, or metastases;medical diagnostic instruments for screening, assessing, and determining appreciate courses of treatment in relation to pre-neoplastic lesions, neoplasms, tumors, cancers and metastases;electronic data storage services, namely, electronic storage of large-scale genomic, metagenomic, proteomic, transcriptomic, epigenetic, and metabolomic data and related clinical data for treatment and diagnostic purposes; database, computer-readable program and software development services, namely, development of scientific, analytical, and statistical software and related databases for use in conjunction with genomic, metagenomic, proteomic, transcriptomic, epigenetic, and metabolomic data gathered from patient clinical care information and medical research data; scientific, chemical, biochemical and microbiological research; scientific research in the field of genetics and genetic engineering of microbes; scientific research in the field of genetic and molecular tests, including tests for microbial populations in vertebrate samples; research and development of therapeutic pharmaceuticals, consumer medical products, diagnostic equipment and prognostic tools consisting of genetically engineered microorganisms, combinations of microorganisms, and individually selected microorganisms for treatment and prevention of pre-neoplastic lesions, neoplasms, tumors, cancers and metastases;